Effect of Subconjunctival Bevacizumab on Primary Pterygium
Teng CC, Patel NN, Jacobson L. Effect of Subconjunctival Bevacizumab on Primary Pterygium. Cornea 2009, 28: 468-470. PMID: 19411971, DOI: 10.1097/ico.0b013e31818d382d.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumabConjunctivaHumansMaleMiddle AgedPterygiumTreatment OutcomeVascular Endothelial Growth Factor AConceptsPrimary pterygiumSubconjunctival bevacizumabEfficacy of bevacizumabNasal primary pterygiumFurther long-term studiesSymptoms of irritationDegree of vascularityML of bevacizumabSurgical excisionTopical proparacaineTotal regressionTopical treatmentArtificial tearsClinical signsPterygium pathogenesisBevacizumab resultsWeeks postinjectionBevacizumabWeek 2PterygiumWeek 7Long-term studiesGrowth factorIrritationShort-term decrease